UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000006872
Receipt number R000008118
Scientific Title A phase II study to confirm the effectiveness of a element supplement "Elental" for patients who are administered TS-1 after surgical resection (OGSG 1108)
Date of disclosure of the study information 2011/12/12
Last modified on 2021/11/23 22:16:59

No. Disposal Last modified on Item of update
1 Insert 2011/12/11 16:18:33
2 Update 2012/01/08 18:32:18 Public title
Public title
Acronym
Acronym
3 Update 2012/06/24 21:59:48 Acronym
Acronym
4 Update 2012/06/24 22:05:01 Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization1
Address1
Tel1
Email1
5 Update 2013/05/31 22:10:40 Anticipated trial start date
Last follow-up date
6 Update 2014/12/16 21:31:10 Recruitment status
Last follow-up date
7 Update 2015/06/10 00:50:25 Organization
Organization
Address
Address
TEL
Email
Email
Email
Institutions
8 Update 2016/06/11 21:04:08 Name of primary person or sponsor
Organization
9 Update 2018/04/30 23:43:16 Email
Email
10 Update 2018/05/10 20:30:32 Email
Email
11 Update 2018/08/01 21:58:02 UMIN ID1
12 Update 2018/08/01 22:00:16 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
13 Update 2020/01/05 21:36:56 Date of IRB
Last follow-up date
Date analysis concluded
14 Update 2020/01/05 21:38:10 Number of participants that the trial has enrolled
Results Delayed
Results Delay Reason
Results Delay Reason
15 Update 2020/01/22 22:13:46 Date of IRB
16 Update 2020/01/22 22:14:21 Recruitment status
17 Update 2021/11/23 22:16:59 URL releasing protocol
Publication of results
URL related to results and publications
Results
Results
Results date posted
Results Delayed
Results Delay Reason
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures